RISK SCORE PREDICTION MODEL FOR DEMENTIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: AN UPDATE SYSTEMATIC REVIEW

Suwandhi; Ayyub

doi:10.61841/7tzs2y21

Authors

Suwandhi Faculty of Medicine, Muhammadiyah University, Semarang, Indonesia Author
Ayyub Faculty of Medicine, Sultan Agung Islamic University, Semarang, Indonesia Author

DOI:

https://doi.org/10.61841/7tzs2y21

Keywords:

Type 2 diabetes mellitus, dementia, risk score.

Abstract

Background: Dementia is a substantial global health issue. Reduction in future numbers of dementia cases through effective preventive strategies could significantly affect the personal and socioeconomic burdens of dementia. WHO has recommended that countries urgently develop national public health programmes to reduce the impact of dementia.

The aim: The aim of this study to show about risk score prediction model for dementia in patients with type 2 diabetes mellitus.

Methods: By the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. This search approach, publications that came out between 2014 and 2024 were taken into account. Several different online reference sources, like Pubmed, SagePub, and Google Scholar were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.

Result: In the PubMed database, the results of our search get 67 articles, whereas the results of our search on SagePub get 210 articles, on Google Scholar 1350 articles. Records remove before screening are 667, so we get 960 articles fos screening. After we screened based on record exclude, we compiled a total of 10 papers. We included five research that met the criteria.

Conclusion: RxDx-Dementia risk index to predict dementia in patients with type 2 diabetes and hypertension. The RxDx-Dementia risk index which incorporated diagnosis and prescription-based information in a single summary score performed better than diagnosis- or prescription-based comorbidity scores or its combinations. The RxDx-Dementia risk index can be used for prognostic purpose or to control confounding in epidemiological studies.

References

Albai O, Frandes M, Timar R, Roman D, Timar B. Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment. Neuropsychiatr Dis Treat. 2019;15:167–75.

Cheng Y, Gadd DA, Gieger C, Monterrubio-Gómez K, Zhang Y, Berta I, et al. Development and validation of DNA methylation scores in two European cohorts augment 10-year risk prediction of type 2 diabetes. Nat Aging. 2023;3(4):450–8.

Liao HH, Livneh H, Huang HL, Hung JY, Lu MC, Guo HR, et al. Reduced risk of dementia in patients with type 2 diabetes mellitus using Chinese herbal medicine: A nested case-control study. World J Diabetes. 2023;14(11):1632–42.

Stephan BCM, Pakpahan E, Siervo M, Licher S, Muniz-Terrera G, Mohan D, et al. Prediction of dementia risk in low-income and middle-income countries (the 10/66 Study): an independent external validation of existing models. Lancet Glob Heal [Internet]. 2020;8(4):e524–35. Available from: http://dx.doi.org/10.1016/S2214109X(20)30062-0

Anstey KJ, Zheng L, Peters R, Kootar S, Barbera M, Stephen R, et al. Dementia Risk Scores and Their Role in the Implementation of Risk Reduction Guidelines. Front Neurol. 2022;12(January 2022):1–12.

Zuñiga AMO, Simó R, Rodriguez-Gómez O, Hernández C, Rodrigo A, Jamilis L, et al. Clinical applicability of the specific risk score of dementia in type 2 diabetes in the identification of patients with early cognitive impairment: Results of the mopead study in Spain. J Clin Med. 2020;9(9):1–10.

Bello-Chavolla OY, Aguilar-Salinas CA, Avila-Funes JA. The type 2 diabetes-specific dementia risk score (DSDRS) is associated with frailty, cognitive and functional status amongst Mexican community-dwelling older adults. BMC Geriatr. 2020;20(1):1–10.

Fayosse A, Nguyen DP, Dugravot A, Dumurgier J, Tabak AG, Kivimäki M, et al. Risk prediction models for dementia: Role of age and cardiometabolic risk factors. BMC Med. 2020;18(1):1–10.

Liu G, Li Y, Xu Y, Li W. Type 2 diabetes is associated with increased risk of dementia, but not mild cognitive impairment: a cross-sectional study among the elderly in Chinese communities. Front Aging Neurosci. 2022;14(September):1–8.

Ren L, Liang J, Wan F, Wang Y, Dai XJ. Development of a Clinical Risk Score Prediction Tool for 5-, 9-, and 13-Year Risk of Dementia. JAMA Netw Open. 2022;5(11):E2242596.

Lee S, Zhou J, Leung KSK, Wu WKK, Wong WT, Liu T, et al. Development of a predictive risk model for allcause mortality in patients with diabetes in Hong Kong. BMJ Open Diabetes Res Care. 2021;9(1):1–12.

Walters K, Hardoon S, Petersen I, Iliffe S, Omar RZ, Nazareth I, et al. Predicting dementia risk in primary care: Development and validation of the Dementia Risk Score using routinely collected data. BMC Med [Internet]. 2016;14(1):1–12. Available from: http://dx.doi.org/10.1186/s12916-016-0549-y

Anatürk M, Patel R, Ebmeier KP, Georgiopoulos G, Newby D, Topiwala A, et al. Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts. BMJ Ment Heal. 2023;26(1):1–7.

Mehta HB, Mehta V, Tsai CL, Chen H, Aparasu RR, Johnson ML. Development and validation of the RxDxdementia risk index to predict dementia in patients with type 2 diabetes and hypertension. J Alzheimer’s Dis. 2015;49(2):423–32.

Huang CY, Lin YC, Lu YC, Chen CI. Application of Grey Relational Analysis to Predict Dementia Tendency by Cognitive Function, Sleep Disturbances, and Health Conditions of Diabetic Patients. Brain Sci. 2022;12(12):1–14.